Log in to your Inderes Free account to see all free content on this page.
Ascelia Pharma
3.43 SEK
+11.18 %
Less than 1K followers
ACE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Ascelia Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -17.8 | -21.9 | -67.8 | -20.3 | -23.0 | -15.3 | -15.8 | -74.4 |
| EBIT | -17.8 | -21.9 | -67.8 | -20.3 | -23.0 | -15.3 | -15.8 | -74.4 |
| EBIT-% | ||||||||
| Profit before taxes | -21.8 | -28.4 | -80.1 | -21.9 | -23.2 | -15.7 | -15.9 | -76.7 |
| Net income | -21.7 | -28.3 | -80.0 | -21.7 | -23.0 | -15.7 | -15.9 | -76.3 |
Login required
This content is only available for logged in users